Multiple opioid receptors
1981; Wiley; Volume: 1; Issue: 4 Linguagem: Romeno
10.1002/med.2610010406
ISSN1098-1128
AutoresEdgar T. Iwamoto, William R. Martin,
Tópico(s)Receptor Mechanisms and Signaling
ResumoMedicinal Research ReviewsVolume 1, Issue 4 p. 411-440 Article Multiple opioid receptors† Edgar T. Iwamoto, Edgar T. Iwamoto Department of Pharmacology, Albert B. Chandler College of Medicine, University of Kentucky, Lexington, Kentucky 40536 Edgar T. Iwamoto was born on November 4, 1947, in Baltimore, MD, he received the B.S. degree (1969, Chemistry) from the University of Illinois, Champaign, and the Ph.D. (1973, Pharmacology) from the University of California, San Francisco. While a graduate student, he served as an Edith Claypole and E. E. Dowdle Fellow. Subsequently he served as an Assistant Research Pharmacologist (1973–1976) and Assistant Professor (1977–1978) at the University of California, San Francisco. In 1978, he was appointed Assistant Professor of Pharmacology, University of Kentucky, Albert B. Chandler Medical Center, Lexington, KY. His research interests include neurochemical mechanisms of opiate action, opioid peptide actions on biogenic amines and axonal protein transport in the CNS. Dr. Iwamoto is a member of the Society for Neuroscience and the American Society for Pharmacology and Experimental Therapeutics.Search for more papers by this authorWilliam R. Martin, William R. Martin Department of Pharmacology, Albert B. Chandler College of Medicine, University of Kentucky, Lexington, Kentucky 40536 William R. Martin received and MD and an MS in Pharmacology from the College of Medicine, University of Illinois, Chicago in 1953. He was an instructor and Assistant Professor at the Department of pharmacology, University of Illinois College of Medicine from 1954 to1957, Neuropharmacologist at the NIMH Addiction Research Center from 1957 to 1963, Director of the National Institute of Drug Abuse, Addiction Research Center, Lexington, KY, 1963 to1977. In 1977, he was appointed Chairman of the Department of Pharmacology, University of Kentucky, Albert B. Chandler Medical Center, Lexington, KY. His research interests include opioid and sedative hyprotic receptors, sympathetic adrenergic processes in the spinal cord, mechanisms of tolerance and dependence, drug addiction, and studies of the psychopathology and pathophysiology of the antisocial personality.Search for more papers by this author Edgar T. Iwamoto, Edgar T. Iwamoto Department of Pharmacology, Albert B. Chandler College of Medicine, University of Kentucky, Lexington, Kentucky 40536 Edgar T. Iwamoto was born on November 4, 1947, in Baltimore, MD, he received the B.S. degree (1969, Chemistry) from the University of Illinois, Champaign, and the Ph.D. (1973, Pharmacology) from the University of California, San Francisco. While a graduate student, he served as an Edith Claypole and E. E. Dowdle Fellow. Subsequently he served as an Assistant Research Pharmacologist (1973–1976) and Assistant Professor (1977–1978) at the University of California, San Francisco. In 1978, he was appointed Assistant Professor of Pharmacology, University of Kentucky, Albert B. Chandler Medical Center, Lexington, KY. His research interests include neurochemical mechanisms of opiate action, opioid peptide actions on biogenic amines and axonal protein transport in the CNS. Dr. Iwamoto is a member of the Society for Neuroscience and the American Society for Pharmacology and Experimental Therapeutics.Search for more papers by this authorWilliam R. Martin, William R. Martin Department of Pharmacology, Albert B. Chandler College of Medicine, University of Kentucky, Lexington, Kentucky 40536 William R. Martin received and MD and an MS in Pharmacology from the College of Medicine, University of Illinois, Chicago in 1953. He was an instructor and Assistant Professor at the Department of pharmacology, University of Illinois College of Medicine from 1954 to1957, Neuropharmacologist at the NIMH Addiction Research Center from 1957 to 1963, Director of the National Institute of Drug Abuse, Addiction Research Center, Lexington, KY, 1963 to1977. In 1977, he was appointed Chairman of the Department of Pharmacology, University of Kentucky, Albert B. Chandler Medical Center, Lexington, KY. His research interests include opioid and sedative hyprotic receptors, sympathetic adrenergic processes in the spinal cord, mechanisms of tolerance and dependence, drug addiction, and studies of the psychopathology and pathophysiology of the antisocial personality.Search for more papers by this author First published: Winter 1981 https://doi.org/10.1002/med.2610010406Citations: 110 † This review is dedicated to our dear friend and colleague, Dr. Abraham Wikler, 1910--1981. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 J. Pohl, Z. Exp. Pathol. Therap., 17, 370 (1915). 2 E. R. Hart, J. Pharmacol. Exp. Ther., 72, 19 (1941). 3 E. R. Hart and E. L. McCawley, J. Pharmacol. Exp. Ther., 82, 339 (1944). 4 J. Weijlard and A. E. Erickson, J. Am. Chem. Soc., 64, 869 (1942). 5 K. Unna, J. Pharmacol. Exp. Ther., 79, 27 (1943). 6 L. Lasagna and H. K. Beecher, J. Pharmacol. Exp. Ther., 112, 356 (1954). 7 H. Isbell, Merck Rep., 62, 23 (1953). 8 A. Wikler, H. F. Fraser, and H. Isbell, J. Pharmacol. Exp. Ther., 109, 8 (1953). 9 J. E. Eckenhoff, J. D. Elder, and B. D. King, Am. J. Med. Sci., 223, 191 (1952). 10 A. S. Keats and J. Telford, J. Pharmacol. Exp. Ther., 119, 370 (1957). 11 E. L. May and J. H. Ager, J. Org. Chem., 24, 1432 (1959). 12 S. Archer, N. F. Albertson, L. S. Harris, A. K. Pierson, J. G. Bird, A. S. Keats, J. Telford, and C. N. Papadopoulos, Science, 137, 541 (1962). 13 L. S. Harris and A. K. Pierson, J. Pharmacol. Exp. Ther., 143, 141 (1964). 14 A. S. Keats and J. Telford, J. Pharmacol. Exp. Ther., 143, 157 (1964). 15 L. Lasagna, Proc. R. Soc. Med., 58, 978 (1965). 16 H. F. Fraser and D. E. Rosenberg, J. Pharmacol. Exp. Ther., 143, 149 (1964). 17 W. R. Martin, H. F. Fraser, C. W. Gorodetzky, and D. E. Rosenberg J. Pharmacol. Exp. Ther., 150, 426 (1965). 18 W. R. Martin and C. W. Gorodetzky, J. Pharmacol. Exp. Ther., 150, 437 (1965). 19 D. R. Jasinski, W. R. Martin, and R. D. Hoeldtke, Clin. Pharmacol. Therap., 11, 385 (1970). 20 R. W. Houde and S. L. Wallenstein, Fed. Proc., 15, 440 (1956). 21 W. R. Martin, Pharmacol. Rev., 19, 463 (1967). 22 D. R. Jasinski, W. R. Martin, and C. A. Haertzen, J. Pharmacol. Exp. Ther., 157, 420 (1967). 23 W. R. Martin, D. R. Jasinski, and P. A. Mansky, Arch. Gen. Psychiatry, 28, 784 (1973). 24 M. Weinstock, Br. J. Pharmacol., 17, 433 (1961). 25 L. Grumbach and H. I. Chernov, J. Pharmacol. Exp. Ther., 149, 385 (1965). 26 G. K. W. Yim, H. H. Keasling, E. G. Gross, and C. W. Mitchell, J. Pharmacol. Exp. Ther., 115, 96 (1955). 27 H. Blumberg, P. S. Wolf, and H. B. Dayton, Proc. Soc. Exp. Biol. Med., 118, 763 (1965). 28 R. I. Taber, D. D. Greenhouse, and S. Irwin, Nature, 204, 189 (1964). 29 R. I. Taber, D. D. Greenhouse, J. K. Rendell, and S. Irwin, J. Pharmacol. Exp. Ther., 169, 29 (1969). 30 P. S. Portoghese, J. Med. Chem., 8, 609 (1965). 31 W. R. Martin, C. G. Eades, J. A. Thompson, R. E. Huppler, and P. E. Gilbert, J. Pharmacol. Exp. Ther., 197, 517 (1976). 32 P. E. Gilbert and W. R. Martin, J. Pharmacol. Exp. Ther., 198, 66 (1976). 33 W. R. Martin, C. G. Eades, W. O. Thompson, J. A. Thompson, and H. G. Flanary, J. Pharmacol. Exp. Ther., 189, 759 (1974). 34 P. E. Gilbert and W. R. Martin, Drug Alcoh. Depend., 1, 373 (1976). 35 H. H. Swain and M. H. Seevers, Addendum to the Proceedings of the 36th Annual Meeting of the Committee on Problems of Drug Dependence, 1974, p. 1168. 36 W. R. Martin, C. G. Eades, P. E. Gilbert, and J. A. Thompson, Substance Alcoh. Actions/Misuse, 1, 269 (1980). 37 C. Schneider, Nature, 220, 586 (1968). 38 H. O. J. Collier and C. Schneider: Agonist and Antagonist Actions of Narcotic Analgesic Drugs, University Park, Baltimore, 1973, p. 128. 39 L. Ahtee and I. Kääriäinen, Eur. J. Pharmacol., 22, 206 (1973). 40 S. G. Holtzman and R. E. Jewett, J. Pharmacol. Exp. Ther., 187, 380 (1973). 41 W. R. Buckett and J. S. Shaw, Psychopharmacology, 42, 293 (1975). 42 G. Curzon, J. C. R. Fernando, and A. J. Lees, Br. J. Pharmacol., 66, 573 (1979). 43 S. G. Holtzman and R. E. Jewett, J. Pharmacol. Exp. Ther., 181, 346 (1972). 44 E. T. Iwamoto, J. Pharmacol. Exp. Ther., 217, 451 (1981). 45 A. Cowan, personal communication. 46 P. Tepper and J. H. Woods, Psychopharmacology, 58, 125 (1978). 47 W. F. Michne, T. R. Lewis, S. J. Michalec, A. K. Pierson, M. G. C. Gillan, S. J. Paterson, L. E. Robson, and H. W. Kosterlitz, Characteristics and Function of Opioids, Elsevier, Amsterdam, 1978, p. 197. 48 K. Ramabadran and J. J. C. Jacob, Life Sci., 24, 1959 (1979). 49 J. H. Woods, C. B. Smith, F. Medzihradsky, and H. H. Swain, Mechanism of Pain and Analgesic Compounds, Raven, New York, 1979, p. 429. 50 E. T. Iwamoto and E. L. Way, Adv. Biochem. Psychopharmacol., 20, 357 (1979). 51 H. Pollard, C. Llorens, J. C. Schwartz, C. Gros, and F. Dray, Brain Res., 151, 392 (1978). 52 P. L. Wood, M. Stotland, J. W. Richard, and A. Rackham, J. Pharmacol. Exp. Ther., 215, 697 (1980). 53 A. M. DiGiulio, A. Groppetti, F. Cattabeni, C. L. Galli, A. Maggi, S. Algeri, and F. Ponzio, Eur. J. Pharmacol., 52, 201 (1978). 54 B. A. Berkowitz, Eur. J. Pharmacol., 26, 359 (1974). 55 S. G. Holtzman, Bioch. Pharmacol., 23, 3029 (1974). 56 P. Moleman and J. Bruinvels, Nature, 281, 686 (1979). 57 A. Cowan, P. W. Dettmar, and D. S. Walter, J. Pharm. Pharmacol., 27, 15 (1975). 58 E. T. Iwamoto, H. H. Loh, and E. L. Way, J. Pharmacol. Exp. Ther., 197, 503 (1976). 59 E. T. Iwamoto, Pharmacology, 22, 171 (1980). 60 E. T. Iwamoto, unpublished observations. 61 E. T. Iwamoto and E. L. Way, J. Pharmacol. Exp. Ther., 203, 347 (1977). 62 E. T. Iwamoto, Proceedings of the 42nd Annual Meeting of the Committee on Problems of Drug Dependence, Hyannis, MA, 1980. 63 M. B. Tyers, Br. J. Pharmacol., 69, 503 (1980). 64 J. P. O'Callaghan and S. G. Holtzman, J. Pharmacol. Exp. Ther., 192, 497 (1975). 65 W. D. Gray, A. C. Osterberg, and T. J. Scuto, J. Pharmacol. Exp. Ther., 172, 154, (1970). 66 A. Cowan, R. J. Tallarida, J. Maslow, and M. W. Adler, Abstracts of the Seventh International Congress of Pharmacology, Paris, 1978, p. 168. 67 J. Pearl and L. S. Harris, J. Pharmacol. Exp. Ther., 154, 319 (1966). 68 T. L. Yaksh and T. A. Rudy, Eur. J. Pharmacol., 46, 83 (1977). 69 H. O. Schild, Pharmacol. Rev., 9, 242 (1957). 70 L. L. Hernández and J. B. Appel, Psychopharmacology, 67, 155 (1980). 71 L. A. Dykstra, J. Pharmacol. Exp. Ther., 211, 722 (1979). 72 A. Cowan, E. B. Geller, and M. W. Adler, Science, 206, 465 (1979). 73 T. H. Lanthorn, M. A. Smith and R. L. Isaacson, Neuropharmacology, 18, 743 (1979). 74 W. B. Pickworth and L. G. Sharpe, Neuropharmacology, 18, 617 (1979). 75 F. C. Tortella, A. Cowan, and M. W. Adler, Neuropharmacology, 19, 845 (1980). 76 A. Cowan, P. W. Dettmar, and G. Metcalf, Endogenous and Exogenous Opiate Agonists and Antagonists, Pergamon, New York, 1979, p. 475. 77 S. J. Ward, G. Metcalf, and J. M. H. Rees, Characteristics and Function of Opioids, Elsevier, Amsterdam, 1978, p. 497. 78 C. E. Rosow, J. M. Miller, and J. Cochin, Fed. Proc. Abstr., 38, 681, (1979). 79 D. Römer, H. Büscher, R. C. Hill, R. Maurer, T. J. Petcher, H. B. A. Welle, H. C. C. K. Bakel, and A. M. Akkerman, Life Sci., 27, 971 (1980). 80 H. Merz and K. Stockhaus, J. Med. Chem., 22, 1475 (1979). 81 F. J. Laska and M. R. Fennessy, Eur. J. Pharmacol., 48, 57 (1978). 82 M. R. Fennessy and F. J. Laska, Psychopharmacology, 64, 277 (1979). 83 S. J. Ward, C. F. C. Smith, G. Metcalf, and J. M. H. Rees, Endogenous and Exogenous Opiate Agonists and Antagonists, Pergamon, New York, 1979, p. 103. 84 N. B. Eddy and E. L. May, Science, 181, 407 (1973). 85 G. J. Gwynn, Ph.D. dissertation, University of Michigan, Ann Arbor, MI, 1979. 86 J. J. Teal and S. G. Holtzman, J. Pharmacol. Exp. Ther., 215, 369 (1980). 87 J. J. Teal and S. G. Holtzman, Eur. J. Pharmacol., 68, 1 (1980). 88 S. G. Holtzman, J. Pharmacol. Exp. Ther., 214, 614 (1980). 89 Robert L. Balster, personal communication. 90 S. Herling, E. H. Coale, Jr., R. J. Valentino, D. W. Hein, and J. H. Woods, J. Pharmacol. Exp. Ther., 214, 139 (1980). 91 S. Herling, E. H. Coale, Jr., D. W. Hein, G. Winger, and J. H. Woods, Psychopharmacology, to appear. 92 D. W. Hein, A. M. Young, S. Herling, and J. H. Woods, J. Pharmacol. Exp. Ther., to appear. 93 D. M. Kuhn, I. Greenberg, and J. B. Appel, J. Pharmacol. Exp. Ther., 196, 121 (1976). 94 L. L. Hernández and J. B. Appel, Behav. Neur. Biol., 26, 384 (1979). 95 J. B. Appel, D. M. Kuhn, and F. J. White, Drug Discrimination and State Dependent Learning, Academic, New York, 1978, p. 149. 96 R. A. Harris, J. Pharmacol. Exp. Ther., 213, 497 (1980). 97 J. D. Leander and D. W. McMillan, J. Pharmacol. Exp. Ther., 201, 434 (1977). 98 J. D. Leander, J. Pharmacol. Exp. Ther., 201, 434 (1978). 99 J. D. Leander, Psychopharmacology, 63, 81 (1979). 100 D. Snell and R. Adron Harris, personal communication. 101 J. A. H. Lord, A. A. Waterfield, J. Hughes, and H. W. Kosterlitz, Nature, 267, 495 (1977). 102 H. W. Kosterlitz, J. A. H. Lord, S. J. Paterson, and A. A. Waterfield, Br. J. Pharmacol., 68, 333 (1980). 103 W. R. Martin, P. E. Gilbert, J. A. Thompson, and C. A. Jessee, Drug Alcoh. Depend., 3, 23 (1978). 104 H. W. Kosterlitz and S. J. Paterson, Proc. R. Soc. London Ser. B, 210, 113, (1980). 105 H. W. Kosterlitz and A. A. Waterfield, Ann. R. Pharm., 15, 29 (1975). 106 M. Hutchinson, H. W. Kosterlitz, F. M. Leslie, A. A. Waterfield, and L. Terenius, Br. J. Pharmacol., 55, 541 (1975). 107 T.-P. Su, T. H. Clements, and C. W. Gorodetzky, Life Sci., 28, 2519 (1981). 108 H. W. Kosterlitz, A. C. Waterfield, and V. Berthoud, Adv. Biochem. Psychopharmacol., 8, 319 (1974). 109 Y. Audigier, H. Mazarguil, J. Rossier, and J. Cros, Eur. J. Pharmacol., 68, 237 (1980). 110 B. P. Roques, G. Gacel, M.-C. Fournie-Zaluski, B. Senault, and J.-M. Lecomte, Eur. J. Pharmacol., 60, 109 (1979). 111 A. A. Waterfield, J. Hughes, and H. W. Kosterlitz, Nature, 260, 624, (1976). 112 P. Illes, W. Zieglgänsberger, and A. Herz, Brain Res., 197, 260 (1980). 113 R. Schulz, M. Wüster, H. Krenss, and A. Herz, Nature, 285, 242 (1980). 114 J. Hughes, H. W. Kosterlitz, and F. M. Leslie, Br. J. Pharmacol., 53, 371 (1975). 115 S. Lemaire, J. Magnan, and D. Regoli, Br. J. Pharmacol., 64, 327 (1978). 116 R. Schulz, E. Faase, M. Wüster, and A. Herz, Life Sci., 24, 843 (1979). 117 M. Wüster, R. Schulz, and A. Herz, Neurosci. L., 15, 193 (1979). 118 M. Wüster, R. Schulz, and A. Herz, Life Sci., 27, 163 (1980). 119 R. Schulz, M. Wüster, H. Krenss, and A. Herz, personal communication. 120 F. Huidobro, J. P. Huidobro-Toro, and H. Miranda, Br. J. Pharmacol., 70, 519 (1980). 121 Y. F. Jacquet, Science, 210, 95 (1980). 121a A. L. Tatum, M. H. Seevers, and K. H. Collins, J. Pharmacol. Exp. Ther., 36, 447 (1929). 122 R. Schulz and A. Herz, Life Sci., 19, 1117 (1976). 123 A. Goldstein, S. Tachibana, L. I. Lowney, M. Hunkapiller, and L. Hood, Proc. Natl. Acad. Sci., 76, 6666 (1979). 124 M. Wüster, R. Schulz, and A. Herz, Eur. J. Pharmacol., 62, 235 (1980). 125 J. M. Hiller and E. J. Simon, Eur. J. Pharmacol., 60, 389 (1979). 126 J. M. Hiller and E. J. Simon, J. Pharmacol. Exp. Ther., 214, 516 (1980). 127 K.-J. Chang, E. Hazum, and P. Cuatrecasas, Proc. Natl. Acad. Sci., 77, 4469, (1980). 128 G. W. Pasternak, Proc. Natl. Acad. Sci., 77, 3691 (1980). 129 D. W. Harris and V. H. Sethy, Eur. J. Pharmacol., 66, 121 (1980). 130 H. W. Kosterlitz and F. M. Leslie, Br. J. Pharmacol., 64, 607 (1978). 131 C. B. Pert, S. H. Snyder, and E. L. May, J. Pharmacol. Exp. Ther., 196, 316 (1976). 132 L. E. Robson and H. W. Kosterlitz, Proc. R. Soc. London Ser. B, 205, 425, (1979). 133 M. G. C. Gillan, H. W. Kosterlitz, and S. J. Paterson, Br. J. Pharmacol., 70, 481 (1980). 134 W. A. Hewlett, H. Akil, and J. D. Barchas, Endogenous and Exogenous opiate Agonists and Antagonists, Pergamon, New York, 1979, p. 95. 135 S. J. Ward, P. S. Portoghese, and A. E. Takemorei, Soc. Neurosci. Abst., 6, 525 (1980). 136 P. S. Portoghese, D. L. Larson, L. M. Sayre, D. S. Fried, and A. E. Takemori, J. Med. Chem., 23, 233 (1980). 137 A. E. Takemori, D. L. Larson, and P. S. Portoghese, Eur. J. Pharmacol. to appear. 138 A. Czlonkowski, V. Hollt, and A. Herz, Life Sci., 22, 953 (1978). 139 E. Somoza, Neuropharmocology, 17, 577 (1978). 140 D. T. Wong and J. S. Horng, Res. Commun. Chem. Pathol. Pharmacol., 16, 749, (1977). 141 K.-J. Chang and P. Cautrecasas, J. Biol. Chem., 254, 2610 (1979). 142 K.-J. Chang, B. R. Cooper, E. Hazum, and P. Cautrecasas, Mol. Pharmacol., 16, 91 (1979). 143 P.-Y. Law and H. H. Loh, Res. Commun. Chem. Pathol. Pharmacol., 21, 409 (1978). 144 S. R. Childers, I. Creese, A. M. Snowman, and S. H. Snyder, Eur. J. Pharmacol., 55, 11 (1979). 145 F. M. Leslie, C. Chavkin, and B. M. Cox, J. Pharmacol. Exp. Ther., 214, 395 (1980). 146 L. Terenius and A. Wahlstrom, Eur. J. Pharmacol., 40, 241 (1976). 147 L. Terenius, Psychoneuroendo., 2, 53 (1977). 148 L. Terenius, Receptors for Neurotransmitters and Peptide Hormones, Raven, New York, 1980, p. 321. 149 A. A. Waterfield, F. M. Leslie, J. A. H. Lord, N. Ling, and H. W. Kosterlitz, Eur. J. Pharmacol., 58, 11 (1979). 150 C. B. Pert and D. Taylor, Endogenous and Exogenous Opiate Agonists and Antagonists, Pergamon, New York, 1979, p. 87. 151 S. H. Snyder and R. R. Goodman, J. Neurochem., 35, 5 (1980). 152 M. Herkenham and C. B. Pert, Proc. Natl. Acad. Sci., 77, 5532 (1980). 153 C. B. Pert, Neurosecretion and Brain Peptides; Implications for Brain Function and Neurologic Disease, Ravin, New York, 1981. 154 W. S. Young, III and M. J. Kuhar, Brain Res., 179, 255 (1979). 155 R. R. Goodman, S. H. Snyder, M. J. Kuhar and W. S. Young, III, Proc. Natl. Acad. Sci., 77, 6239 (1980). 156 M. E. Lewis, M. Mishkin, E. Bragin, R. M. Brown, C. B. Pert, and A. Pert, Science, 211, 1166 (1981). 157 A.-Z. Zhang and G. W. Pasternack, Eur. J. Pharmacol., 67, 323 (1980). 158 G. W. Pasternak, S. R. Childers, and S. H. Snyder, Science, 208, 514 (1980). 159 J. E. Villarreal, Agonist and Antagonist Actions of Narcotic Analgesic Drugs, H. W. Kosterlitz, H. O. J. Collier, and J. E. Villarreal, Eds., Macmillan, London, 1972, p. 73. 160 W. R. Martin and D. R. Jasinski, Drug Addiction I, W. R. Martin, Ed., Springer-Verlag, Berlin, 1977, p. 159. 161 W. R. Martin, The Bases of Addiction, J. Fishman, Ed., Dahlem Konferenzen, Berlin, 1978, p. 395. 162 W. R. Martin, Life Sci., 28, 1547 (1981). 163 W. R. Martin, Life Sci., 28, 1555 (1981). Citing Literature Volume1, Issue4Winter 1981Pages 411-440 ReferencesRelatedInformation
Referência(s)